Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious respiratory diseases
Biotech
Novo Nordisk Foundation sets up $260M vaccine initiative
The Novo Nordisk Foundation is dedicating up to $260 million to create new or improved vaccines for serious respiratory diseases.
Gabrielle Masson
Dec 18, 2023 11:14am
Sanger Institute launches virus sequencing initiative
Jan 13, 2023 7:35am
Pfizer nabs RSV biotech ReViral in quick $525M bolt-on
Apr 7, 2022 8:27am
Ex-FDA interim head Giroir returns to biotech to make antivirals
Feb 11, 2022 10:00am
Pfizer kick-starts phase 3 respiratory syncytial virus trial
Sep 3, 2021 7:18am
Pfizer jumps the queue and leaps into RSV vax contention
Jul 30, 2021 5:10am